Results 201 to 210 of about 6,238 (230)

Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss

open access: yesClinical Obesity, Volume 16, Issue 1, February 2026.
ABSTRACT Early response (ER) to treatment is predictive of longer‐term weight loss. In this post hoc analysis, ER to an oral shape‐shifting superabsorbent hydrogel capsule (Epitomee) combined with a lifestyle intervention was compared to placebo combined with a lifestyle intervention.
John M. Jakicic   +11 more
wiley   +1 more source

Against the Manhattan project framing of AI alignment

open access: yesMind &Language, Volume 41, Issue 1, Page 119-136, February 2026.
In response to the worry that autonomous generally intelligent artificial agents may at some point take over control of human affairs a common suggestion is that we should “solve the alignment problem” for such agents. We show that current discourse around this suggestion often uses a particular framing of artificial intelligence (AI) alignment as ...
Simon Friederich, Leonard Dung
wiley   +1 more source

Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV. [PDF]

open access: yesSouth Afr J HIV Med
Macdonald P   +11 more
europepmc   +1 more source

Genome‐Edited Maize Expressing Two Native Genes Confers Broad‐Spectrum Resistance to Northern Corn Leaf Blight

open access: yesMolecular Plant Pathology, Volume 27, Issue 2, February 2026.
We identified a novel resistance allele, NLB18‐R, at the Htn1 locus. Using CRISPR‐Cas9, we replaced the susceptible allele (NLB18‐S) with NLB18‐R in an elite inbred. We stacked NLB18‐R and the resistance gene Ht1‐R. The resulting genome‐edited plants exhibited resistance to Setosphaeria turcica races 0, 1 and 23N.
Huirong Gao   +20 more
wiley   +1 more source

Advances in HIV Treatment and Vaccine Development: Emerging Therapies and Breakthrough Strategies for Long-Term Control. [PDF]

open access: yesAIDS Res Treat
Okesanya OJ   +9 more
europepmc   +1 more source

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis. [PDF]

open access: yesJ Med Chem
Canales E   +46 more
europepmc   +1 more source

Rare but serious: pulmonary vascular disease around the world. [PDF]

open access: yesJHLT Open
Hjalmarsson C   +6 more
europepmc   +1 more source

Lenacapavir: Playing the Long Game in the New Era of Antiretrovirals. [PDF]

open access: yesClin Pharmacol Ther
Neverette NC   +3 more
europepmc   +1 more source

Not All Rhinitis Follows the Atopic March: Early‐Life Risk Factors and Implications of Infectious Disease Across Three Phenotypes in JECS Cohort

open access: yes
Allergy, Volume 81, Issue 2, Page 585-590, February 2026.
Daisuke Harama   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy